Sample records for 161sm 160-165eu 163gd

  1. Identification of new neutron-rich rare-earth nuclei produced in /sup 252/Cf spontaneous fission

    CERN Document Server

    Greenwood, R C; Gehrke, R J; Meikrantz, D H


    A program of systematic study of the decay properties of neutron-rich rare-earth nuclei with 30 s163/Gd (t/sub 1 /2/=68+or-3 s), in addition to 5.51 min /sup 158/Sm which was identified in an earlier series of experiments. (11 refs).

  2. Pure cerium dioxide preparation for use as spectrochemical standard and analysed by inductively coupled plasma mass spectrometry (SF ICP-MS)

    International Nuclear Information System (INIS)

    For several years, IPEN/CNEN-SP has been working in the separation of the Rare Earth (RE) elements. A simple and economic procedure for the purification of technical grade cerium concentrate is described. The highly pure cerium dioxide is designed to be used as spectrochemical standard. It is obtained by association of the fractional precipitation technique, in the system RECl3/NH4OH/ Air/H2O2, to enrich the cerium up to 90% and then it is upgraded by ion exchange technique to 99.99% CeO2. The quality control warranty was accomplished by inductively coupled mass spectrometry (ICP-MS) and neutron activation analysis. The collected values for the accompanying Rare Earth elements in a CeO2 sample are the following (ppm): La(36), Pr(19), Nd(161), Sm(11), Eu(5.3), Gd(113), Tb(89), Dy(2), Ho(0.05), Er(1), Tm(<0.05), Yb(11), Lu(19) and Y(2.1), respectively. The purity of this cerium oxide is comparable to the international spectrographic standards. (author)

  3. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients. (United States)

    Vouk, Katja; Ribič-Pucelj, Martina; Adamski, Jerzy; Rižner, Tea Lanišnik


    Endometriosis is a complex, polygenic, and estrogen-dependent disease that affects 6% to 10% of women of reproductive age, and 30% to 50% of women with infertility and/or pelvic pain. Surgical diagnosis of endometriosis is still the gold standard, as there are currently no diagnostic biomarkers available. Due to the invasive diagnostics, it can take up to 11 years before affected women are diagnosed and receive the appropriate treatment. We performed a targeted metabolomics study to search for potential semi-invasive biomarkers in peritoneal fluid from endometriosis patients. Our case-control study comprised 29 ovarian endometriosis patients and 36 healthy control women. The 148 metabolites included acylcarnitines, glycerophospholipids, and sphingolipids, which were quantified by electrospray ionization tandem mass spectrometry. The strength of association between the metabolites and the metabolite ratios and disease was assessed using crude and adjusted odds ratios. The best combination of biomarkers was then selected by performing step-wise logistic regression. Our analysis reveals significantly decreased concentrations of 10 metabolites, of carnitine and acylcarnitines (C0, C8:1, C6C4:1 DC, C10:1), phosphatidylcholines (PC aa C38:3, PC aa C38:4, PC aa C40:4, PC aa C40:5), and sphingomyelins (SM C16:1, SM C18:1), and 125 significantly altered metabolite ratios in patients versus control women. The best model includes two ratios: a carnitine to a phosphatidylcholine (C0/PC ae C36:0); and between two phosphatidylcholines (PC aa C30:0/PC ae C32:2). When adjusted for age, this provides sensitivity of 82.8% and specificity of 94.4%, with AUC of 0.944. Our study supports the importance of carnitine, phosphatidylcholine, and sphingomyelin metabolites in the pathophysiology of endometriosis, and confirms the potential for the combination of individual metabolite ratios to provide biomarkers for semi-invasive diagnostics. PMID:26921767